Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


29.03.2021

2 Am J Surg
1 Ann Oncol
4 BMC Cancer
2 BMC Gastroenterol
6 Br J Cancer
5 Br J Surg
5 Cancer Lett
1 Clin Cancer Res
1 Eur J Cancer
1 Eur J Surg Oncol
7 Gastroenterology
1 Gut
1 Int J Cancer
2 Int J Colorectal Dis
1 Int J Oncol
2 J Am Coll Surg
1 J Nucl Med
2 J Surg Oncol
1 Oncogene
1 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg

  1. REYNOLDS IS, Cromwell PM, Hoti E
    Clinicopathological characteristics and survival outcomes for patients with mucinous colorectal cancer liver metastases undergoing hepatic resection: A systematic review and meta-analysis.
    Am J Surg. 2021 Mar 3. pii: S0002-9610(21)00112.
    PubMed         Abstract available

  2. LIU MM, Miller MO, Merrell SB, Bruce JS, et al
    A comparison of provider perspectives on cultural competency training: A mixed methods study.
    Am J Surg. 2021;221:356-362.
    PubMed         Abstract available


    Ann Oncol

  3. CARMONA-BAYONAS A, Jimenez-Fonseca P, Valenti V, Salazar R, et al
    Bayesian interpretation of the ESMO guideline for localized colorectal cancer: a better IDEA.
    Ann Oncol. 2021 Mar 16. pii: S0923-7534(21)00878.
    PubMed        


    BMC Cancer

  4. CHEN J, Song Y, Li M, Zhang Y, et al
    Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer.
    BMC Cancer. 2021;21:255.
    PubMed         Abstract available

  5. LV Z, Liang Y, Liu H, Mo D, et al
    Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study.
    BMC Cancer. 2021;21:306.
    PubMed         Abstract available

  6. SHIRAISHI T, Ikeda K, Tsukada Y, Nishizawa Y, et al
    High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer.
    BMC Cancer. 2021;21:302.
    PubMed         Abstract available

  7. HUANG CC, Liu FR, Feng Q, Pan XY, et al
    RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480.
    BMC Cancer. 2021;21:321.
    PubMed         Abstract available


    BMC Gastroenterol

  8. ZHAO L, Zhang X, Chen Y, Wang Y, et al
    Does self-reported symptom questionnaire play a role in nonadherence to colonoscopy for risk-increased population in the Tianjin colorectal cancer screening programme?
    BMC Gastroenterol. 2021;21:117.
    PubMed         Abstract available

  9. VEETTIL SK, Kew ST, Lim KG, Phisalprapa P, et al
    Very-low-dose aspirin and surveillance colonoscopy is cost-effective in secondary prevention of colorectal cancer in individuals with advanced adenomas: network meta-analysis and cost-effectiveness analysis.
    BMC Gastroenterol. 2021;21:130.
    PubMed         Abstract available


    Br J Cancer

  10. LI YY, Gao LJ, Zhang YX, Liu SJ, et al
    Bisphosphonates and risk of cancers: a systematic review and meta-analysis.
    Br J Cancer. 2020;123:1570-1581.
    PubMed         Abstract available

  11. HE F, Ju HQ, Ding Y, Jiang Z, et al
    Association between adjuvant chemotherapy and survival in patients with rectal cancer and pathological complete response after neoadjuvant chemoradiotherapy and resection.
    Br J Cancer. 2020;123:1244-1252.
    PubMed         Abstract available

  12. PAPE J, Magdeldin T, Stamati K, Nyga A, et al
    Cancer-associated fibroblasts mediate cancer progression and remodel the tumouroid stroma.
    Br J Cancer. 2020;123:1178-1190.
    PubMed         Abstract available

  13. OUAHOUD S, Jacobs RJ, Peppelenbosch MP, Fuhler GM, et al
    Kinome-wide analysis of the effect of statins in colorectal cancer.
    Br J Cancer. 2021 Mar 19. pii: 10.1038/s41416-021-01318.
    PubMed         Abstract available

  14. GOLDER AM, McMillan DC, Park JH, Mansouri D, et al
    The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: an analysis of 1700 patients.
    Br J Cancer. 2021 Mar 24. pii: 10.1038/s41416-021-01308.
    PubMed         Abstract available

  15. ROSENDAHL HUBER A, Pleguezuelos-Manzano C, Puschhof J
    A bacterial mutational footprint in colorectal cancer genomes.
    Br J Cancer. 2021 Mar 19. pii: 10.1038/s41416-021-01273.
    PubMed         Abstract available


    Br J Surg

  16. JORGREN F, Lydrup ML, Buchwald P
    Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
    Br J Surg. 2020;107:1818-1825.
    PubMed         Abstract available

  17. DENOST Q, Solomon M, Tuech JJ, Ghouti L, et al
    International variation in managing locally advanced or recurrent rectal cancer: prospective benchmark analysis.
    Br J Surg. 2020;107:1846-1854.
    PubMed         Abstract available

  18. LIGHTNER AL, Vaidya P, Vogler S, McMichael J, et al
    Surveillance pouchoscopy for dysplasia: Cleveland Clinic Ileoanal Pouch Anastomosis Database.
    Br J Surg. 2020;107:1826-1831.
    PubMed         Abstract available

  19. VAN OOSTENDORP SE, Smits LJH, Vroom Y, Detering R, et al
    Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.
    Br J Surg. 2020;107:1719-1730.
    PubMed         Abstract available

  20. HEALEY BIRD BRJ
    Total neoadjuvant therapy for locally advanced rectal cancer: the fuse is lit.
    Br J Surg. 2020;107:1705-1707.
    PubMed        


    Cancer Lett

  21. NICOLAZZO C, Barault L, Caponnetto S, De Renzi G, et al
    True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature.
    Cancer Lett. 2021;507:89-96.
    PubMed         Abstract available

  22. TAO H, Cheng L, Liu L, Wang H, et al
    A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activity.
    Cancer Lett. 2020;493:91-101.
    PubMed         Abstract available

  23. HONG EH, Cho J, Ahn JH, Kwon BE, et al
    Plasmacytoid dendritic cells regulate colitis-associated tumorigenesis by controlling myeloid-derived suppressor cell infiltration.
    Cancer Lett. 2020;493:102-112.
    PubMed         Abstract available

  24. PENG W, Zhang C, Peng J, Huang Y, et al
    Lnc-FAM84B-4 acts as an oncogenic lncRNA by interacting with protein hnRNPK to restrain MAPK phosphatases-DUSP1 expression.
    Cancer Lett. 2020;494:94-106.
    PubMed         Abstract available

  25. LIN R, Han C, Ding Z, Shi H, et al
    Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection.
    Cancer Lett. 2020;495:165-179.
    PubMed         Abstract available


    Clin Cancer Res

  26. ARAI H, Elliott A, Xiu J, Wang J, et al
    The landscape of alterations in DNA damage response pathways in colorectal cancer.
    Clin Cancer Res. 2021 Mar 25. pii: 1078-0432.CCR-20-3635.
    PubMed         Abstract available


    Eur J Cancer

  27. ROSATI G, Lonardi S, Galli F, Di Bartolomeo M, et al
    Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
    Eur J Cancer. 2021;148:190-201.
    PubMed         Abstract available


    Eur J Surg Oncol

  28. VAN DEN BERG I, van de Weerd S, van Klaveren D, Coebergh van den Braak RRJ, et al
    Daily practice in guideline adherence to adjuvant chemotherapy in stage III colon cancer and predictors of outcome.
    Eur J Surg Oncol. 2021 Mar 16. pii: S0748-7983(21)00376.
    PubMed         Abstract available


    Gastroenterology

  29. FENG Y, Pauklin S
    Two Sides of the Same Coin: The Roles of Transforming Growth Factor-beta in Colorectal Carcinogenesis.
    Gastroenterology. 2020;159:397-398.
    PubMed        

  30. ZAIDI S, Rao S, Mishra L
    Reply.
    Gastroenterology. 2020;159:398-399.
    PubMed        

  31. TINMOUTH J, Dong S, Stogios C, Rabeneck L, et al
    Estimating the Backlog of Colonoscopy due to Coronavirus Disease 2019 and Comparing Strategies to Recover in Ontario, Canada.
    Gastroenterology. 2021;160:1400-1402.
    PubMed        

  32. BUI TM, Butin-Israeli V, Wiesolek HL, Zhou M, et al
    Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer.
    Gastroenterology. 2021 Mar 19. pii: S0016-5085(21)00536.
    PubMed         Abstract available

  33. INOUE A, Robinson FS, Minelli R, Tomihara H, et al
    Sequential administration of XPO1 and ATR inhibitors enhances therapeutic response in TP53-mutated colorectal cancer.
    Gastroenterology. 2021 Mar 18. pii: S0016-5085(21)00530.
    PubMed         Abstract available

  34. KARLITZ JJ, Montminy EM, Itzkowitz SH
    Adenocarcinomas, as opposed to carcinoids, are primarily driving increases in early-onset colorectal cancer rates.
    Gastroenterology. 2021 Mar 19. pii: S0016-5085(21)00532.
    PubMed        

  35. JOH HK, Lee DH, Hur J, Nimptsch K, et al
    Simple sugar and sugar-sweetened beverage intake during adolescence and risk of colorectal cancer precursors: Adolescent sugar intake and colorectal polyp.
    Gastroenterology. 2021 Mar 19. pii: S0016-5085(21)00537.
    PubMed         Abstract available


    Gut

  36. BURR NE, Plumb A, Sood R, Rembacken B, et al
    CT colonography remains an important test for colorectal cancer.
    Gut. 2021 Mar 22. pii: gutjnl-2021-324399. doi: 10.1136/gutjnl-2021-324399.
    PubMed        


    Int J Cancer

  37. INDUKURI R, Jafferali MH, Song D, Damdimopoulos A, et al
    Genome-Wide Estrogen Receptor beta Chromatin Binding in Human Colon Cancer Cells Reveals its Tumor Suppressor Activity.
    Int J Cancer. 2021 Mar 22. doi: 10.1002/ijc.33573.
    PubMed         Abstract available


    Int J Colorectal Dis

  38. WARPS AK, de Neree Tot Babberich MPM, Dekker E, Wouters MWJM, et al
    Interhospital referral of colorectal cancer patients: a Dutch population-based study.
    Int J Colorectal Dis. 2021 Mar 20. pii: 10.1007/s00384-021-03881.
    PubMed         Abstract available

  39. LANG-SCHWARZ C, Melcher B, Dregelies T, Norouzzadeh Z, et al
    Adjuvant chemotherapy in stage II and III colon cancer: the role of the "budding and TILs-(tumor-infiltrating lymphocytes) combination" as tumor-host antagonists.
    Int J Colorectal Dis. 2021 Mar 20. pii: 10.1007/s00384-021-03896.
    PubMed         Abstract available


    Int J Oncol

  40. ABDULLA MH, Agarwal D, Singh JK, Traiki TB, et al
    Association of the microbiome with colorectal cancer development (Review).
    Int J Oncol. 2021;58.
    PubMed         Abstract available


    J Am Coll Surg

  41. HUNT SR
    Watch-and-Wait as a Strategy for Appropriately Selected Rectal Cancer Patients.
    J Am Coll Surg. 2020;231:692-694.
    PubMed        

  42. RUPPERT R, Kube R, Strassburg J, Lewin A, et al
    Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial.
    J Am Coll Surg. 2020;231:413-425.
    PubMed         Abstract available


    J Nucl Med

  43. ALSULTAN AA, van Roekel C, Barentsz MW, Smits MLJ, et al
    Dose-response and dose-toxicity relationships for yttrium-90 glass radioembolization in patients with colorectal cancer liver metastases.
    J Nucl Med. 2021 Mar 19. pii: jnumed.120.255745. doi: 10.2967/jnumed.120.255745.
    PubMed         Abstract available


    J Surg Oncol

  44. BEHRENBRUCH C, Prabhakaran S, Udayasiri D D, Michael M, et al
    Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study.
    J Surg Oncol. 2021;123:1263-1273.
    PubMed         Abstract available

  45. LEIPHRAKPAM PD, Lazenby AJ, Smith LM, Brattain MG, et al
    Stathmin expression in metastatic colorectal cancer.
    J Surg Oncol. 2021 Mar 25. doi: 10.1002/jso.26464.
    PubMed         Abstract available


    Oncogene

  46. CHUEH AC, Advani G, Foroutan M, Smith J, et al
    CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.
    Oncogene. 2021 Mar 25. pii: 10.1038/s41388-021-01755.
    PubMed         Abstract available


    Oncol Rep

  47. CHEN Z, Zhong T, Zhong J, Tang Y, et al
    MicroRNA129 inhibits colorectal cancer cell proliferation, invasion and epithelialtomesenchymal transition by targeting SOX4.
    Oncol Rep. 2021;45.
    PubMed         Abstract available


    PLoS One

  48. YE P, Cai P, Xie J, Wei Y, et al
    The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248775.
    PubMed         Abstract available

  49. TAUBE M, Peltonen M, Sjoholm K, Palmqvist R, et al
    Long-term incidence of colorectal cancer after bariatric surgery or usual care in the Swedish Obese Subjects study.
    PLoS One. 2021;16:e0248550.
    PubMed         Abstract available

  50. TOYODA Y, Tabuchi T, Hama H, Morishima T, et al
    Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
    PLoS One. 2020;15:e0244644.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: